Stroke: Vascular and Interventional Neurology

JUNE 20, 2024

Stroke: Vascular and Interventional Neurology, Ahead of Print. While traditional vascular risk factors (eg, hypertension, dyslipidemia, tobacco use) account for 20% of the explained variance in carotid atherosclerosis, they remain a prominent focus for primary and secondary ischemic stroke prevention strategies.

Cerebrovascular Disease 40

Cerebrovascular Disease Atherosclerosis Atrial Fibrillation Physiology 40

DAIC

JANUARY 23, 2024

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page AWP222-AWP222, February 1, 2024. Introduction:Moyamoya is a progressive cerebrovascular disease characterized by stenosis of the cerebral arteries in the anterior circulation and less often the posterior circulation. The median time from diagnosis was 0 years (IQR 0, 1.3).

Stenosis 40

Stenosis Sickle Cell Disease Cerebrovascular Disease Pediatrics 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page AWP394-AWP394, February 1, 2025. Background:Our recently reported that patent foramen ovale (PFO) shunt enables the elevation of total homocysteine (tHcy) in patients circulation (Deng, Neurology 2021). However, the underlying molecular mechanism of how tHcy causes PFO-related injury is unclear.

Cerebrovascular Disease 40

Cerebrovascular Disease Stroke Strokes Circulation 40

Stroke Journal

FEBRUARY 1, 2024

Stroke, Volume 55, Issue Suppl_1 , Page ATP284-ATP284, February 1, 2024. Objectives:Moyamoya Disease (MMD) is a progressive occlusive cerebrovascular disease with unknown etiology and pathogenesis.

Cerebrovascular Disease 40

Cerebrovascular Disease Aneurysm Circulation Stroke 40

Stroke Journal

JANUARY 30, 2025

Stroke, Volume 56, Issue Suppl_1 , Page A78-A78, February 1, 2025. Introduction:Intracranial aneurysm (IA), a cerebrovascular disease affecting 3-5% of US population, leads to subarachnoid hemorrage. This demonstrates the potential of using circulating blood to screen for IA presence.

Aneurysm 40

Aneurysm Cerebrovascular Disease Circulation Stroke 40

DAIC

JANUARY 22, 2024

The International Stroke Conference 2024 will be held Feb. According to program planners with the American Stroke Association, a division of the American Heart Association, findings from late-breaking science will include multiple high profile randomized clinical trials like RESILIENT-Extend, EMBOLISE, STEM, ZODIAC, among many others.

Stroke 100

Stroke Strokes Hospital Stent 100